Suchergebnisse - "Wang, Yakun"

PubPharm (9)

1

Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours : a multicentre, open label, dose escalation and expansion phase 1 trial

enthalten in: EClinicalMedicine | 2024

von Wang, Y. | Gong, J. | Wang, A. | +15

2

Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2021

von Xu, Y. | Wang, Y. | Gong, J. | +20

3

Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors

enthalten in: Gastric cancer | 2021

von Xu, Y. | Wang, Y. | Gong, J. | +20

4

Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors

enthalten in: Gastric cancer | 2021

von Xu, Y. | Wang, Y. | Gong, J. | +20

5

Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors

enthalten in: Gastric Cancer | 2021

von Xu, Y. | Wang, Y. | Gong, J. | +20

6

YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling

enthalten in: Journal of cancer research and clinical oncology | 2020

von Zhang, C. | Lin, X. | Zhao, Q. | +7

7

YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling

enthalten in: Journal of cancer research and clinical oncology | 2020

von Zhang, C. | Lin, X. | Zhao, Q. | +7

8

YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling

enthalten in: Journal of cancer research and clinical oncology | 2020

von Zhang, C. | Lin, X. | Zhao, Q. | +7

9

YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling

enthalten in: Journal of cancer research and clinical oncology | 2020

von Zhang, C. | Lin, X. | Zhao, Q. | +7

1
[1]